A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.
Clinical trial NCT04865835 · COMPLETED
Trial details
- NCT number
- NCT04865835
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2022-05-03
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.